The weight loss injection could soon be recognized as a treatment option by statutory health insurance providers if outgoing Barmer CEO Christoph Straub is correct, who emphasizes that drug prices must be aligned with actual benefits and that no prior diet attempts by patients should be required. #Abnehmspritze #Adipositas #Kassenleistung (translated)
